Estimated cost savings and formulary coverage barriers in biosimilar adoption
Abstract
Dermatologists routinely manage chronic inflammatory conditions that rely on high-cost specialty medications, including biologics. To improve access, the FDA has approved biosimilars based on demon...
Fields of Study & Subjects
Biosimilars and Bioanalytical Methods
Pharmaceutical Economics and Policy
Health Systems
Economic Evaluations
Quality of Life
Publication details
- Journal / source
- Journal of Dermatological Treatment
- Volume
- 37
- Issue
- 1
- Pages
- 2610921–2610921
- Publication date
- 13 January 2026
- Language
- EN